The Anti-obesity Effects of Younggyechulgam-tang-ga Hwanggi on Obesity in Mice Induced by High Fat Diet

고지방식이 유도 비만생쥐에 대한 영계출감탕(苓桂朮甘湯) 가(加) 황기(黃芪)의 항비만 효과

  • Jeong, Man-Jin (Department of Rehabilitation Medicine of Korean Medicine, College of Korean Medicine, Daegu Hanny University) ;
  • Woo, Chang-Hoon (Department of Rehabilitation Medicine of Korean Medicine, College of Korean Medicine, Daegu Hanny University) ;
  • Ahn, Hee-Duk (Department of Rehabilitation Medicine of Korean Medicine, College of Korean Medicine, Daegu Hanny University)
  • 정만진 (대구한의대학교 한의과대학 한방재활의학과교실) ;
  • 우창훈 (대구한의대학교 한의과대학 한방재활의학과교실) ;
  • 안희덕 (대구한의대학교 한의과대학 한방재활의학과교실)
  • Received : 2018.03.17
  • Accepted : 2018.03.30
  • Published : 2018.04.30


Objectives This study was conducted to experimentally evaluate the effects of Younggyechulgam-tang-ga Hwanggi(YGT) on obesity in mice induced by high fat diet. Methods The experiment was conducted with 4-week-old male mice divided into 5 groups. They were a normal diet group(Nor), a high fat diet group(Veh), a positive drug control group-orlistat 40 mg/kg(Oris), a 1.08 g/kg group(YGTL), and a 2.16 g/kg group(YGTH), and were tested for five weeks. Changes in antioxidant activity, body weight, organ weight, ROS, AST, ALT, TC, TG, HDL-C, LDL-C and lipid metabolism protein were checked. Results YGTL and YGTH group significantly reduced body weight compared to Veh group. YGTH group significantly reduced visceral fat weights compared to Veh group. In blood biochemistry analysis, ROS, AST, ALT, TC, TG and LDL-C in YGTL and YGTH group were significantly lower than Veh group. HDL-C increased significance in YGTL and YGTH group. In antioxidation protein analysis, Catalase, GPx and HO-1 have increased significantly in YGTL and YGTH group. YGTH group have increased $PPAR-{\alpha}$, p-AMPK compared to Veh group. but decreased FAS. SREBP-1, p-ACC levels in YGTL and YGTH group were decreased compared to Veh group, however CPT-1, UCP-2 levels in YGTL and YGTH group were increased compared to Veh group. Conclusions YGT has anti-obesity effects by regulating lipolysis and antioxidation in a diet-induced obesity model. Additional clinical studies are needed.


  1. The Society of Korean Medicine Rehabilitation. Korea rehabilitation medicine. 4th ed. Seoul:Koonja. 2015:295-319.
  2. Yin J, Zhang H, Ye J. Traditional chinese medicine in treatment of metabolic syndrome. Endocr Metab Immune Disorder Drug Target. 2008;8(2):99-111.
  3. Kim JM, Choi SM, Yang DH, AN HD. The effect of oral administration at herbal medicines in animal models on obesity: a review of animal study reports published in Korea after 2010. Journal of Korean Medicine Rehabilitation. 2017;27(3):13-32.
  4. Kim BT, Cho HG. The Bibliographical Study on Causes, Mechanisms and the Chief Virtues on Obesity. Daejeon University Institute of Oriental Medicine journal. 1992;1(2):61-71.
  5. Jang JG. Junggyeongjeonseo. Seoul:Daeseongmunhwasa. 1984:153-4, 391-2.
  6. Heo J. Donguibogam. Seoul:Bupin Publishes. 2005:291-2, 501.
  7. Hong CH, Kim NK, Lee SH, Du IS, Hwang CY. The immunosuppressive effect of Younggaechulgam-tang through inhibition of nuclear translocation of transcription factor. The Journal of Oriental Medical Ophthalmology & Otolaryngology & Dermatology. 2003;16(2):119-37.
  8. Park SA, Kim TH, Yang KS. Effects of Youngkaechulgamtang on the kidney function. Kor J Pharmacogn. 2000;31(3):364-72.
  9. Kim TH, Yang KS, Park SA. Effects of Youngkaechulgamtang on hepatotoxicity. Kor J Pharmacogn. 1999;30(1):12-7.
  10. Song JS, Lee YJ, Choi JH, Kim JH, Park SY, Seo MS. Three cases of benign paroxymal positional vertigo patient treated with Yeonggyechulgam-tang. The Journal of Oriental Medical Ophthalmology & Otolaryngology & Dermatology. 2010;23(2):210-7.
  11. Association of Professors of Herbology, Korean Medicine. Herbology. Seoul:Yonglimsa;2006: 156-7, 348-9, 579-87.
  12. Liu M, Wu K, Mao X, Wu Y, Ouyang J. Astragalus polysaccharide improves insulin sensitivity in KKAy mice: regulation of PKB/GLUT4 signaling in skeletal muscle. J Ethnopharmacol. 2010;127(1):32-7.
  13. Zou F, Mao XQ, Wang N, Liu J, Ou-Yang JP. Astragalus polysaccharides alleviates glucose toxicity and restores glucose homeostasis in diabetic states via activation of AMPK. Acta Pharmacol Sin. 2009;30(12):1607-15.
  14. Chen R, Shao H, Lin S, Zhang JJ, Xu KQ. Treatment with Astragalus membranaceus produces antioxidative effects and attenuates intestinal mucosa injury induced by intestinal ischemia-reperfusion in rats. Am J Chin Med. 2011;39(5):879-87.
  15. Folin O, Denis W. A colorimetric method for the determination of phenols (and phenol derivatives) in urine. J Biol Chem. 1915;22:305-8.
  16. Chang CC, Yang MH, Wen HM, Chern JC. Estimation of total flavonoid content in propolis by two complementary colorimetric methods. Journal of Food and Drug Analysis. 2002;10(3):178-82.
  17. Blois MS. Antioxidants determination by the use of a stable free radical. Nature. 1958;181:1199-200.
  18. Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med. 1999;26(9-10):1231-7.
  19. Kooy NW, Royall JA, Ischiropoulos H. Oxidation of 2',7'-dichlorofluorescin by peroxynitrite. Free Radic Res. 1997;27(3):245-54.
  20. Korea National Health and Nutrition Examination Survey. 2014. Availrable from:
  21. Lee JS, Lee SH. The reductive effects of oriental medicine on the body fat and abdominal obesity. Journal of Korean Medicine for Obesity Research. 2001;1:33-42.
  22. Kim KS, Park SW. Drug therapy for obesity. Korean J Obes. 2012;21(4):197-202.
  23. Filippatos TD, Derdemezis CS, Gazi IF, Nakou ES, Mikhailidis DP, Elisaf MS. Orlistat-associated adverse effects and drug interactions. Drug saf. 2008;31(1):53-65.
  24. Keum SO, Lee HI, Lee JH, Yoon YI, Kwon YM, Song YS. Effects of Gami-Cheongpyesagan-Tang on body fat in high fat diet-fed obese mice. J Korean Med Obes Res. 2015;15(2):75-92.
  25. Song MY, Kim HJ. Analysis of main single medicinal herbs for anti-obesity. J Korean Med Obes Res. 2013;13(2):51-7.
  26. Yang YG. Naegyeongsomunyeokhae. Seoul:Daeseongmunhwasa. 1990:235-43, 356-61.
  27. Yang YG. Naegyeongyeongchuyeokhae. Seoul:Seongbosa. 1990:303-9.
  28. Kim SH, Lee BJ. The study of record relate with the notion, the diagnosis and treatment for obesity. Daejeon University Institute of Oriental Medicine journal. 1998;7(1):533-41.
  29. Kang SA, Jang KH, Park SK, Lim JP, Jeon H, and Cui X, Leem KH. Effects of herbal composition on obese rats fed high diet. Kor J Herbology. 2003;18(4):59-64.
  30. Kaminaga T, Yasukawa K, Kanno H, Tai T, Nunoura Y, Takido M. Inhibitory effects of lanostane-type triterpene acids, the components of Poria cocos, on tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin. Oncology. 1996;53(5):382-5.
  31. Nukaya H, Yamashiro H, Fukazawa H, Ishida H, Tsuji K. Isolation of inhibitors of TPA-induced mouse ear edema from Hoelen, Poria cocos. Chem Pharm Bull. 1996;44(4):847-9.
  32. Sato M, Tai T, Nunoura Y, Yajima Y, Kawashima S, Tanaka K. Dehydro-trametenolic acid induces preadipocyte differentiation and sensitizes animal models of noninsulin-dependent diabetes mellitus to insulin. Biol Pharm Bull. 2002;25(1):81-6.
  33. Huang B. Anti-obesity effect and action mechanism of cinnamaldehyde in 3T3-L1 adipocyte cells and high fat diet- induced obese mice [dissertation]. [Seoul]:Kyung Hee University;2011.
  34. Kim CK, Kim M, Oh SD, Lee SM, Sun B, Choi GS, Kim SK, Bae H, Kang C, Min BI. Effects of Atractylodes macrocephala Koidzumi rhizome on 3T3-L1 adipogenesis and an animal model of obesity. J ethnopharmacol. 2011;137(1):396-402.
  35. Han Y, Jung HW, Park YK. The roots of Atractylodes japonica Koidzumi promote adipogenic differentiation via activation of the insulin signaling pathway in 3T3-L1 cells. BMC Complement Altern Med. 2012;12(1):154.
  36. Mae T, Kishida H, Nishiyama T, Tsukagawa M, Konishi E, Kuroda M, Mimaki Y, Sashida Y, Takahashi K, Kawada T, Nakagawa K, Kitahara M. A licorice ethanolic extractwith peroxisome proliferator-activated receptor-gamma ligand-binding activity affects diabetes in KK-Ay mice, abdominalobesity in diet-induced obese C57BL mice and hypertension in spontaneously hypertensive rats. J Nutr. 2003;133(11):3369-77.
  37. Ryu SP, Kwon TD, Yoe YG, Kim BS, Lee SCH. Effects of licorice-root-extracted food components ingestion on blood lipids concentration during exercise in rats. The Korean Journal of Physical Education. 2006;45(1):707-13.
  38. Bjorntorp P. The associations between obesity, adipose tissue distribution and disease. Acta Med Scand. 1988;723:121-34.
  39. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radical Bio Med. 2010;49(11):1603-16.
  40. Carriere A, Carmona MC, Fernandez Y, Rigoulet M, Wenger RH, Penicaud L, Casteilla L. Mitochondrial reactive oxygen species control the transcription factor CHOP-10/GADD153 and adipocyte differentiation: a mechanism for hypoxia-dependent effect. J Biol Chem. 2004;279(39):40462-9.
  41. Lee YJ, Yoon BR, Choi HS, Lee BY, Lee OH. Effect of Sargassum micracanthum extract on lipid accumulation and reactive oxygen species (ROS) production during differentiation of 3T3-L1 preadipocytes. Korean J Food Preserv. 2012;19(3):455-61.
  42. Kim JS, Na CS, Kim YG. The involvement of oxygen free radicals in the onset of aging. Korean J ori Med. 1997;3:229-39.
  43. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Biochemical role as a component of glutathione peroxidase. Science. 1973;179(4073):588-90.
  44. Kono Y, Fridovich I. Superoxide radical inhibits catalase. J Biol Chem. 1982;257(10):5751-4.
  45. Surh YJ, Kundu JK, Li MH, Na HK, Cha YN. Role of Nrf2-mediated heme oxygenase-1 upregulation in adaptive survival response to nitrosative stress. Arch Pharm Res. 2009;32(8):1163-76.
  46. Idriss NK, Blann AD, Lip GY. Hemeoxygenase-1 in cardiovascular disease. J Am Coll Cardiol. 2008;52(12):971-8.
  47. Kesavulu MM, Giri R, Kameswara Rao B, Apparao C. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications. Diabetes Metab. 2000;26(5):387-92.
  48. Plaa GL, Charbonneau M. Detection and evaluation of chemically induced liver injury. In:Hayes AW, Kruger CL, eds. Principles and Methods of Toxicology. 3rd ed. New York:Raven Press. 1994:839-70.
  49. Lee GN, Kwon OH. The clinical pathology file. 3rd ed. Seoul:Uihakmunhwasa. 2000:155-99.
  50. Schulze MB, Rimm EB, Shai I, Rifai N, Hu FB. Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes. Diabetes Care. 2004;27(7):1680-7.
  51. Park BS. Effect of the feeding belly fat on plasma lipids levels in rats. Korean J Food Sci Ani Resour. 2004;24(2):189-97.
  52. Tomkin GH. Atherosclerosis, diabetes and lipoproteins. Expert Rev Cardiovasc Ther. 2010;8(7):1015-29.
  53. Nammi S, Sreemantula S, Roufogalis BD. Protective effects of ethanolic extract of Zingiber officinale rhizome on the development of metabolic syndrome in high-fat diet-fed rats. Basic Clin Pharmacol Toxicol. 2009;104(5):366-73.
  54. Kola B, Grossman AB, Korbonits M. The role of AMP-activated protein kinase in obesity. Front Horm Res. 2008;36:198-211.
  55. Nepokroeff CM, Lakshmanan MR, Porter JW. Fatty acid synthase from rat liver. Methods Enzymol. 1975;35:37-44.
  56. Pang J, Choi Y, Park T. Ilex paraguariensis extract ameliorates obesity induced by high-fat diet: potential role of AMPK in the visceral adipose tissue. Arch Biochem Biophys. 2008;476(2):178-85.
  57. Landree LE, Hanlon AL, Strong DW, Rumbaugh G, Miller IM, Thupari JN, Connolly EC, Huganir RL, Richardson C, Witters LA, Kuhajda FP, Ronnett GV. C75, a fatty acid synthase inhibitor, modulates AMP-activated protein kinase to alter neuronal energy metabolism. J Biol Chem. 2004;279(5):3817-27.
  58. Postic C, Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest. 2008;118(3):829-38.
  59. Lapsys NM, Kriketos AD, Lim-Fraser M, Poynten AM, Lowy A, Furler SM, Chisholm DJ, Cooney GJ. Expression of genes involved in lipid metabolism correlate with peroxisome proliferator-activated receptor gamma expression in human skeletal muscle. J Clin Endocrinol Metab. 2000;85(11):4293-7.
  60. Evans RM, Barish GD, Wang YX. PPARs and the complex journey to obesity. Nat Med. 2004;10(4):355-61.
  61. Bruce CR, Hoy AJ, Turner N, Watt MJ, Allen TL, Carpenter K, Cooney GJ, Febbraio MA, Kraegen EW. Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance. Diabetes. 2009;58(3):550-8.
  62. McGarry JD, Brown NF. The mitochondrial carnitine palmitoyltransferase system: from concept to molecular analysis. Eur J Biochem. 1997;244:1-14.
  63. Erlanson-Albertsson C. The role of uncoupling proteins in the regulation of metabolism. Acta Physiol Scand. 2003;178(4):405-12.
  64. Adams SH. Uncoupling protein homologs: emerging views of physiological function. J Nutr. 2000;130(4):711-4.